Human desmoid fibroblasts: Matrix metalloproteinases, their inhibitors and modulation by Toremifene

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Balducci, Chiara ^a   Lilli, Cinzia ^a   Stabellini, Giordano ^b   Marinucci, Lorella ^a   Giustozzi, Giammario ^a   Becchetti, Alessio ^a   Cagini, Lucio ^a   Locci, Paola ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,1,2 TRIPHENYLETHYLENE DERIVATIVE; ANTIESTROGEN; COLLAGEN FIBER; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; THYMIDINE; TISSUE INHIBITOR OF METALLOPROTEINASE; TOREMIFENE; TRITIUM; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; COLLAGEN; COLLAGENASE; MATRIX METALLOPROTEINASE INHIBITOR; PROCOLLAGEN;

ARTICLE; BENIGN TUMOR; CANCER INVASION; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DESMOID TUMOR; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MACROMOLECULE; METASTASIS; PROTEIN EXPRESSION; PROTEIN FAMILY; SKIN FIBROBLAST; TUMOR GROWTH; DRUG EFFECT; FIBROBLAST; FIBROMATOSIS; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC AGENTS, HORMONAL; CELL LINE, TUMOR; COLLAGEN; COLLAGENASES; FIBROBLASTS; FIBROMATOSIS, AGGRESSIVE; HUMANS; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASES; TOREMIFENE; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 26844456483     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-22     Document Type: Article

References (37)

1. Eccles DM, Van Der Luijt R, Breukel C, Bullman H, Bunyan D, Fisher A, Barber J, Boulayc DU, Primrose J, Burn J, Fodde R: Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet 1996, 59:1193-1201.
2. Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brenna MF: The enigma of desmoid tumors. Ann Surg 1999, 229:866-878.
3. Locci P, Bellocchio S, Lilli C, Marinucci L, Cagini L, Baroni T, Giustozzi G, Becchetti E: Synthesis and secretion of transforming growth factor-β1 by human desmoid fibroblast cell line and its modulation by toremifene. J Interf Cytok Res 2001, 21:961-970.
4. Massagué J, Blain SW, Lo RS: TGFβ signalling in growth control, cancer and heritable disorders. Cell 2000, 103:295-309.
5. Pasque B: Role of TGF-beta in cancer. J Cell Physiol 2001, 186:53-168.
6. Lilli C, Marinucci L, Bellocchio S, Ribatti D, Balducci C, Baroni T, Cagini L, Locci P: Effects of tranforming growth factor-b1 and tumour necrosis factor-a on cultured fibroblasts from skin fibroma as modulated by toremifene. Int J Cancer 2002, 98:824-832.
7. Birkedal-Hansen H, Moore WGL, Bodden MW, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993, 4:197-250.
8. Mao D, Lee JK, VanVickle SJ, Thompson W: Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. Biochem Bioph Res Co 1999, 261:904-910.
9. Kahari VM, Saarialho-Kere U: Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 1999, 31:34-35.
10. Shapiro SD: Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Bio 1998, 10:602-608.
11. Veli-Matti K, Saarialho-Kere U: Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 1999, 31:34-45.
12. Aimes RT, Quigley JP: Matrix metalloproteinase is an interstitial collagenase. J Biol Chem 1995, 270:5872-5876.
13. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997, 74:111-122.
14. 3. Am J Physiol 1999, 276:814-824.
15. Brooks MD, Ebbs SR, Colletta AA, Baum M: Desmoid tumours treated with triphenylethylenes. Eur J Cancer 1992, 28:1014-1018.
16. Serpell JW, Paddle Ledinek JE, Johnson WR: Modification of growth of desmoid tumours in tissue culture by anti-oestrogenic substances: a preliminary report. Aust N Z J Surg 1996, 66:457-463.
17. Webster DF, Harvey WA: A quantitative assay for collagen synthesis in micro-well fibroblast cultures. Anal Biochem 1979, 96:220-224.
18. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
19. Khorramizadeh MR, Tredget EE, Telasky C, Shen Q, Ghahary A: Aging differentially modulates the expression of collagen and collagenase in dermal fibroblasts. Mol Cell Biochem 1999, 194:99-108.
20. Gogly B, Groult N, Hornebeck W, Godeau G, Pellat B: Collagen zymography as a sensitive and specific technique for the determination of subpicogram levels of interstitial collagenase. Anal Bioch 1998, 255:211-216.
21. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
22. Lowry OH, Rosebrough NJ, Farr AJ, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:265-275.
23. Bodo M, Carinci P, Baroni T, Bellucci C, Giammarioli C, Pezzetti F, Becchetti E: Role of growth factors on extracellular matrix production by chick embryo fibroblasts in vitro. Antagonist effect of TGF-β through the control of IL-1 and IL-1Ra secretion. Cytokine 1998, 10:353-360.
24. Locci P, Baroni T, Lilli C, Martinese D, Marinucci L, Bellocchio S, Calvitti M, Becchetti E: TGF-β and TGF-α, antagonist effect in vitro on extracellular matrix accumulation by chick skin fibroblasts at two distinct embryonic stages. Int J Dev Biol 1999, 43:157-165.
25. Murray GI, Duncan ME, Arbuckle E, Melvin WT, Tothergill JE: Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 1998, 43:791-797.
26. Naito Y, Ohori K, Tanaka M, Kamo T, Baba S, Hori T, Hashizume K, Sugimura H: Collagen and elastin synthesis by desmoid tumour in vitro. Pathol Int 1998, 48:603-610.
27. Johnsen M, Lund LR, Romer J, Almholt K, Dano K: Cancer invasion and tissue remodelling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 1998, 10:667-671.
28. Schmalfeldt B, Prechtel D, Harting K, Spathe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W, Lengyel E: Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 2001, 7:2396-2404.
29. Nemeth JA, Yousif R, Herzog M, Che M, Upadhyay J, Shekarriz B, Bhagat S, Mullins C, Fridman R, Cher ML: Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. Cancer Spectrum 2002, 94:17-25.
30. Skiles JW, Gonnella NC, Jeng AY: The design, structure and therapeutic application of matrix metalloproteinase inhibitors. Curr Med Chem 2001, 8:425-474.
31. Nishioka Y, Sagae S, Nishikawa A, Ishioka S, Kudo R: A relationship between matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression. Cancer Lett 2003, 200:49-55.
32. Kanayama H, Yokota K, Kurokawa Y, Murakami Y, Nishitani M, Kagawa S: Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer 1998, 82:1359-1366.
33. Bernardo MM, Fridman R: TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochem J 2003, 374:735-739.
34. Dong Z, Nemeth JA, Cher ML, Palmer KC, Bright RC, Fridman R: Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells. Int J Cancer 2001, 93:507-515.
35. Liu XW, Bernardo MM, Fridman R, Kim HR: Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J Biol Chem 2003, 278:40364-72.
36. Cotrim P, de Andrade CR, Martelli-Junior H, Graner E, Sauk JJ, Coletta RD: Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta 1 autocrine stimulation. J Periodontol 2002, 73:1313-1322.
37. Hirata M, Sato T, Tsumagari M, Shimada A, Nakano H, Hashizume K, Ito A: Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro. Biol Reprod 2003, 68:1276-1281.